Hong Kong Drug Office Updates Frequently Asked Questions’ Page

Hong Kong Drug Office has provided the latest set of frequently asked questions (FAQs) on their official website at the …

read more...

Australia TGA Publishes Guidance on Standards for Biologicals for Labelling Requirements

The Therapeutic Goods Administration (TGA) Australia has published a new guidance on Therapeutic Goods Orders (TGO) 107 to provide a …

read more...

Australia TGA Publishes Guidance on Standards for Biologicals

he Therapeutic Goods Administration (TGA) Australia has published a new guidance on Therapeutic Goods Orders (TGO) 109 to provide a …

read more...

Hong Kong Drug Office Updates Frequently Asked Questions’ Page

Hong Kong Drug Office has updated and included the latest set of frequently asked questions (FAQs) on their official website …

read more...

Australia TGA Publishes Guidance on Standard for Human Cell or Tissue Products

The Therapeutic Goods Administration (TGA) Australia has published a guidance document for Therapeutic Goods Orders (TGO) 108 for manufacturers and sponsors of biologicals and human cell or …

read more...

Philippines FDA Issues Circular on Revised Post-Marketing Surveillance Requirements for New Drugs under Monitored Release

The Philippines Food and Drug Administration (FDA) has issued Circular No. 2021-020 to provide updated post-marketing surveillance (PMS) requirements for new drugs under monitored release, …

read more...

China NMPA Implements Drug eCTD Submission

On 30 September 2021, China NMPA issued an announcement No. 119 of 2021 regarding implementation of drug eCTD submission.   From December 29, 2021, applications for …

read more...

HSA Singapore Introduces an Online Self-Guided Tool for Post-approval Minor Variation Applications

HSA Singapore has launched on 20 August 2021 a new online self-guided tool for post-approval minor variation applications (MIV) to help industry stakeholders …

read more...

Hong Kong Drug Office Publishes Guidance Note on Registration of Pharmaceutical Products Containing a New Chemical or Biological Entity

Hong Kong Drug Office has published a guidance note on the registration of pharmaceutical products containing a new chemical or …

read more...

More News